insights_auto
Why is EDIT down 3,61%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
2,40 US$
arrow_downward
-3,61%(-0,090) 1D
2,44 US$
arrow_upward
+1,53% (+0,037)bedtimeAfter hours
Closed: 23 ოქტ, 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
2,44 US$
High
2,45 US$
Low
2,30 US$
Mkt. cap
368,59 მლნ.
Avg. vol.
2,92 მლნ.
Volume
1,31 მლნ.
52-wk high
3,94 US$
52-wk low
1,66 US$
EPS
-0,74 US$
Beta
2,00
Shares outstanding
153,58 მლნ.
No. of employees
87
Open
2,44 US$
High
2,45 US$
Low
2,30 US$
Mkt. cap
368,59 მლნ.
Avg. vol.
2,92 მლნ.
Volume
1,31 მლნ.
52-wk high
3,94 US$
52-wk low
1,66 US$
EPS
-0,74 US$
Beta
2,00
Shares outstanding
153,58 მლნ.
No. of employees
87
News stories
From web sources and news partners
Cassandra Unchained | Michael Burry
·
15 საათის წინ
Foundations: The Fate of the S&P 500’s Worst Stocks, the Y2K Analogue, and Time for Small Caps?
Yardeni QuickTakes
·
8 საათის წინ
US MARKETS CALL: Still Proceeding Cautiously
Investor's Business Daily
·
7 საათის წინ
What To Do In A Doom-And-Bloom Market; 3 Titans Loom
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc